Ocular Therapeutix
OCUL
OCUL
184 hedge funds and large institutions have $1.45B invested in Ocular Therapeutix in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 75 increasing their positions, 48 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
6% less funds holding
Funds holding: 196 → 184 (-12)
29% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 31
Holders
184
Holding in Top 10
10
Calls
$9.7M
Puts
$4.1M
Top Buyers
| 1 | +$173M | |
| 2 | +$19.5M | |
| 3 | +$12.5M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$6.81M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.85M |
Top Sellers
| 1 | -$13.6M | |
| 2 | -$12.2M | |
| 3 | -$6.71M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$6.12M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$4.04M |
